What 4 Analyst Ratings Have To Say About Xeris Biopharma Holdings
Analysts have provided the following ratings for Xeris Biopharma Holdings (NASDAQ:XERS) within the last quarter:
Benzinga Pro’s Top 5 Stocks To Watch For Friday, Dec. 31, 2021: XERS, NTRB, MDRR, ZEPP, NIO
Today's 5 Stock Ideas:
Xeris Biopharma (XERS) - Shares up ~23%. The company announced FDA approval of Recorlev for the treatment of endogenous hypercortisolemia in adult patients with Cushing's
18 Stocks Moving in Friday’s Pre-Market Session
Gainers
Medalist Diversified REIT, Inc. (NASDAQ: MDRR) rose 34.3% to $1.37 in pre-market trading after the company reported a stock repurchase program of 500,000 shares.
SVB Leerink Maintains Outperform on Xeris Biopharma Holdings, Raises Price Target to $8
SVB Leerink analyst Roanna Ruiz maintains Xeris Biopharma Holdings (NASDAQ:XERS) with a Outperform and raises the price target from $6 to $8.
A Peek Into The Markets: US Stock Futures Edge Lower On Final Trading Day Of 2021
Pre-open movers
U.S. stock futures traded slightly lower in early pre-market trade on the final trading day of 2021. The Dow Jones dropped around 90 points, snapping a six-session winning streak on Thursday.
HC Wainwright & Co. Maintains Buy on Xeris Biopharma Holdings, Raises Price Target to $5.4
HC Wainwright & Co. analyst Oren Livnat maintains Xeris Biopharma Holdings (NASDAQ:XERS) with a Buy and raises the price target from $4.25 to $5.4.
5 Stocks To Watch For December 31, 2021
Some of the stocks that may grab investor focus today are:
Medalist Diversified REIT, Inc. (NASDAQ: MDRR) reported a stock repurchase program of 500,000 shares. Medalist Diversified shares climbed 22.6% to $1.25 in the after-hours trading session.
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022
Biotech stocks remain poised to eke out modest gains for 2021 after the stellar gains of the previous year. COVID-19 drug and vaccine developers experienced volatility throughout 2021 amid delays in programs and the reemergence of variant strains.